Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction-Reference-Cited by-同舟云学术

Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction

Published:2016-12 Issue:7 Volume:1 Page:633-643
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Ali Muhammad,Pulli Benjamin,Courties Gabriel,Tricot Benoit,Sebas Matthew,Iwamoto Yoshiko,Hilgendorf Ingo,Schob Stefan,Dong Anping,Zheng Wei,Skoura Athanasia,Kalgukar Amit,Cortes Christian,Ruggeri Roger,Swirski Filip K.,Nahrendorf Matthias,Buckbinder Leonard,Chen John W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy;Sutton;Circulation,2000

2. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities;Gajarsa;Heart Fail Rev,2011

3. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both;Solomon;N Engl J Med,2005

4. Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study;Gerber;Am J Epidemiol,2013

5. Long-term trends in the incidence of heart failure after myocardial infarction;Velagaleti;Circulation,2008

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of myeloperoxidase to treat left ventricular dysfunction in non‐ischaemic cardiomyopathy;European Journal of Heart Failure;2024-08-30

2. Comprehensive macro and micro views on immune cells in ischemic heart disease;Cell Proliferation;2024-08

3. The role of NETosis in heart failure;Heart Failure Reviews;2024-07-29

4. Immuno-inflammatory pathogenesis in ischemic heart disease: perception and knowledge for neutrophil recruitment;Frontiers in Immunology;2024-07-10

5. Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction;Antioxidants;2024-06-28